Actelion Needs Further Studies on Opsumit Treatment for Inoperable CTEPH, US FDA Says
CTEPH News, News
Actelion Pharmaceuticals has received a complete response letter from the U.S. Food and Drug Administration (FDA) specifying that the company needs to conduct further studies and obtain more data in order ... Read more